[1] KITAHARA C M, SOSA J A. The changing incidence of thyroid cancer [J]. Nat Rev Endocrinol, 2016,12(11):646-653. [2] PEREIRA J A, JIMENO J, MIQUEL J, et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma [J]. Surgery, 2005,138(6):1095-1101. [3] ITO Y, MIYAUCHI A. Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma:indications, benefits, and risks [J]. World J Surg, 2007, 31(5):905-915. [4] SIEGEL R L, MILLER K D, FUCHS H E, et al. Cancer Statistics, 2021 [J]. CA Cancer J Clin, 2021,71(1):7-33. [5] HAUGEN B R, ALEXANDER E K, BIBLE K C, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer [J]. Thyroid, 2016,26(1):1-133. [6] ZEITOUNI M, CLARE R M, CHISWELL K, et al. Risk factor burden and long-term prognosis of patients with premature coronary artery disease [J]. J Am Heart Assoc, 2020,9(24):e17712. [7] 张璧珠, 耿丽娜, 林昊,等. 女性分化型甲状腺癌患者术后促甲状腺激素水平与高胆固醇血症关系研究[J].临床耳鼻咽喉头颈外科杂志,2020,34(6):554-557. [8] DAMIANO F, ROCHIRA A, GNONI A, et al. Action of thyroid hormones, T3 and T2, on hepatic fatty acids: differences in metabolic effects and molecular mechanisms [J]. Int J Mol Sci, 2017,18(4):744. [9] GNOCCHI D, STEFFENSEN K R, BRUSCALUPI G, et al. Emerging role of thyroid hormone metabolites [J]. Acta Physiol (Oxf), 2016,217(3):184-216. [10] CAIN W J, MILLAR J S, HIMEBAUCH A S, et al. Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a] [J]. J Lipid Res,2005,46(12):2681-2691. [11] SNIDERMAN A D. ApoB vs non-HDL-C vs LDL-C as markers of cardiovascular disease [J]. Clin Chem, 2021,67(11):1440-1442. [12] van der BOOM T, JIA C, LEFRANDT J D, et al. HDL cholesterol efflux capacity is impaired in severe short-term hypothyroidism despite increased HDL cholesterol [J]. J Clin Endocrinol Metab, 2020,105(9):E3355-E3362. [13] LU L, WANG B, SHAN Z, et al. The correlation between thyrotropin and dyslipidemia in a population-based study [J]. J Korean Med Sci, 2011,26(2):243-249. [14] YANG C, LU M, CHEN W, et al. Thyrotropin aggravates atherosclerosis by promoting macrophage inflammation in plaques [J]. J Exp Med, 2019,216(5):1182-1198. [15] DELLA TORRE S, MITRO N, FONTANA R, et al. An essential role for liver erα in coupling hepatic metabolism to the reproductive cycle [J]. Cell Rep, 2016,15(2):360-371. |